MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-GJ-01-0022880
Market Cap
₹10.33 Cr
DPL · BSE
Share Price
₹3.89
-1.02% today
Revenue
₹129 Cr
FY 2025-26 · +3.4% YoY
EBITDA
₹5.02 Cr
Margin 3.9%
Net Profit
₹2.63 Cr
FY 2025-26 · +171.1% YoY
P/E (TTM)
4.1x
P/B 0.2x
Authorised capital
₹28.5 Cr
Registered with MCA
Paid-up capital
₹26.29 Cr
Issued & subscribed
About Dipna Pharmachem Limited
Data last updated:
Dipna Pharmachem Limited is a public limited company based in Ahmedabad, Gujarat, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 19 July 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L24100GJ2011PLC066400. Its GSTIN is 24AADCD9404F1ZY (Gujarat). It is a listed company as per MCA records. Its shares are listed on BSE: 543594.
The company has an authorised share capital of ₹28.5 Cr and a paid-up capital of ₹26.29 Cr. It was formerly known as Dipan Pharmachem Private Limited and Dipna Pharmachem Private Limited. It is led by directors including Keyur Dipakkumar Shah (Managing Director) and Dipna Keyur Shah.
Its last annual general meeting (AGM) was held on 30 August 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at A/211 Siddhi Vinayak Complex Near D.A.V. School Makarba, Ahmedabad, Gujarat, India – 380055.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹129.11 Cr, a growth of 3.4% compared to the previous year. For the same year it recorded a net profit of ₹2.63 Cr (net margin 2%) and EBITDA of ₹5.02 Cr (EBITDA margin 3.9%).
The company is associated with 1 brand: Dipna Pharmachem. As per MCA filings, the company has open charges of ₹11.38 Cr and satisfied charges of ₹4.2 Cr on record. Court records list 54 cases involving the company, including 1 filed by the company and 53 filed against it; 31 cases are pending. The company has 82 deals on record (79 market trades, 2 rights issues, 1 ipo); the latest was in August 2026.
Dipna Pharmachem Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0022880). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dipnapharmachem.com.
Company details
CIN L24100GJ2011PLC066400
Registration Number 066400
Incorporation Date 19 July 2011
ROC Ahmedabad
Listing Status Listed - Listed on BSE (543594)
Company Status Active
Date of Last AGM 30 August 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-GJ-01-0022880
Name history
Dipna Pharmachem has undergone 2 name changes throughout its history. The company was previously known as Dipan Pharmachem Private Limited, and Dipna Pharmachem Private Limited. The current legal name is Dipna Pharmachem Limited.
| Company Name | Status |
|---|---|
| Dipna Pharmachem Limited | Current |
| Dipan Pharmachem Private Limited | Previous |
| Dipna Pharmachem Private Limited | Previous |
CIN history
Dipna Pharmachem has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24100GJ2011PLC066400, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24100GJ2011PLC066400 | Current |
| U24100GJ2011PLC066400 | Previous |
| U24100GJ2011PTC066400 | Previous |
Key People
Keyur Dipakkumar Shah Managing Director Dipna Keyur Shah Director Jitendra Pradipbhai Parmar Additional Director Recognitions & Rankings of Dipna Pharmachem
Contact details
Dipna Pharmachem Limited's registered office is in Ahmedabad, Gujarat. Its website is dipnapharmachem.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA/211 Siddhi Vinayak Complex Near D.A.V. School Makarba, Ahmedabad, Gujarat, India – 380055
- IndustryChemicals and Materials, Chemical Distribution & Retail
To see the full contact details of Dipna Pharmachem Limited, buy the company report.
Comprehensive company report
Dipna Pharmachem Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Dipna Pharmachem operates one associated brand: Dipna Pharmachem. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Distributor of pharmaceutical raw materials | dipnapharmachem.com |
Business activity
The main business activity of Dipna Pharmachem is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Dipna Pharmachem Limited, buy the company report.
Financials of Dipna Pharmachem Limited
FY 2025-26 filings availableDipna Pharmachem Limited reported revenue of ₹129.11 Cr (up 3.4% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue
₹129 Cr
+3.4% YoY
EBITDA
₹5.02 Cr
+34.2% YoY
Profit After Tax
₹2.63 Cr
+171.1% YoY
Net Worth
-
Total Assets
-
Total Debt
-
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 129 | 125 | 164 | 99.93 | 72.76 | 31.00 | 30.54 |
| Revenue growth | +3.4% | -24.0% | +64.5% | +37.3% | +134.7% | +1.5% | - |
| EBITDA | 5.02 | 3.74 | 3.44 | 2.36 | 2.18 | 0.40 | 0.47 |
| EBITDA margin | +3.9% | +3.0% | +2.1% | +2.4% | +3.0% | +1.3% | +1.5% |
| Profit before tax | 3.55 | 1.42 | 1.41 | 1.39 | 1.57 | 0.06 | 0.08 |
| Net profit | 2.63 | 0.97 | 1.07 | 0.92 | 1.16 | 0.03 | 0.08 |
| Net profit margin | +2.0% | +0.8% | +0.7% | +0.9% | +1.6% | +0.1% | +0.3% |
| EPS (₹) | 1.00 | 0.41 | 0.45 | 0.76 | 333.39 | 6.91 | 16.86 |
| Balance sheet | |||||||
| Total assets | - | 55.72 | 56.96 | 40.27 | 11.93 | 13.00 | 10.12 |
| Net worth | - | 38.50 | 37.52 | 24.36 | 1.74 | 0.58 | 0.55 |
| Total debt | - | 17.22 | 19.45 | 15.91 | 10.19 | 12.43 | 9.57 |
| Cash & bank | - | 0.43 | 13.88 | 5.69 | 0.21 | 0.25 | 0.18 |
| Net working capital | - | 55.68 | 56.93 | 40.22 | 11.88 | 12.97 | 10.08 |
| Cash flow | |||||||
| Cash from operations | - | (9.19) | (5.42) | (20.98) | 2.81 | (2.43) | (3.12) |
| Cash from investing | - | (0.02) | (0.01) | (0.01) | (0.01) | 0.00 | 0.01 |
| Cash from financing | - | (4.24) | 13.62 | 26.47 | (2.84) | 2.50 | 3.17 |
| Particulars | Mar 2026 | Dec 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|
| Revenue | 2.05 | 53.52 | 15.92 | 18.39 |
| Revenue growth (YoY) | -87.1% | +191.0% | - | - |
| Other income | 0.00 | 0.00 | 0.00 | 0.00 |
| Total expenses | 1.59 | 51.86 | 14.63 | 17.70 |
| EBITDA | 0.46 | 1.66 | 1.29 | 0.69 |
| EBITDA margin | +22.8% | +3.1% | +8.1% | +3.8% |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.23 | 0.23 | 0.60 | 0.40 |
| Profit before tax | 0.23 | 1.43 | 0.69 | 0.29 |
| Tax | 0.05 | 0.37 | 0.18 | 0.15 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 23 Oct 2026
| Particulars | Mar 2026 | Dec 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|
| Revenue | 2.05 | 53.52 | 15.92 | 18.39 |
| Revenue growth (YoY) | -87.1% | +191.0% | - | - |
| Other income | 0.00 | 0.00 | 0.00 | 0.00 |
| Total expenses | 1.59 | 51.86 | 14.63 | 17.70 |
| EBITDA | 0.46 | 1.66 | 1.29 | 0.69 |
| EBITDA margin | +22.8% | +3.1% | +8.1% | +3.8% |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.23 | 0.23 | 0.60 | 0.40 |
| Profit before tax | 0.23 | 1.43 | 0.69 | 0.29 |
| Tax | 0.05 | 0.37 | 0.18 | 0.15 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 129 | 125 | 164 | 99.93 | 72.76 | 31.00 | 30.54 |
| Revenue growth | +3.4% | -24.0% | +64.5% | +37.3% | +134.7% | +1.5% | - |
| Other income | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.02 | 0.01 |
| Total expenses | 124 | 121 | 161 | 97.57 | 70.58 | 30.60 | 30.07 |
| Employee cost | 0.00 | 0.41 | 0.44 | 0.00 | 0.00 | 0.41 | 0.38 |
| EBITDA | 5.02 | 3.74 | 3.44 | 2.36 | 2.18 | 0.40 | 0.47 |
| EBITDA margin | +3.9% | +3.0% | +2.1% | +2.4% | +3.0% | +1.3% | +1.5% |
| Depreciation | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
| Interest | 1.46 | 2.32 | 2.01 | 0.97 | 0.61 | 0.35 | 0.39 |
| Profit before tax | 3.55 | 1.42 | 1.41 | 1.39 | 1.57 | 0.06 | 0.08 |
| Tax | 0.92 | 0.45 | 0.34 | 0.47 | 0.41 | 0.03 | 0.00 |
| Net profit | 2.63 | 0.97 | 1.07 | 0.92 | 1.16 | 0.03 | 0.08 |
| Net profit margin | +2.0% | +0.8% | +0.7% | +0.9% | +1.6% | +0.1% | +0.3% |
| EPS (₹) | 1.00 | 0.41 | 0.45 | 0.76 | 333.39 | 6.91 | 16.86 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | - | 24.05 | 24.05 | 11.97 | 0.04 | 0.04 | 0.04 |
| Reserves & surplus | - | 14.45 | 13.47 | 12.39 | 1.70 | 0.54 | 0.51 |
| Shareholders' funds (net worth) | - | 38.50 | 37.52 | 24.36 | 1.74 | 0.58 | 0.55 |
| Secured loans | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | - | 17.22 | 19.45 | 15.91 | 10.19 | 12.43 | 9.57 |
| Total debt | - | 17.22 | 19.45 | 15.91 | 10.19 | 12.43 | 9.57 |
| Total liabilities | - | 55.72 | 56.96 | 40.27 | 11.93 | 13.00 | 10.12 |
| Assets | |||||||
| Gross block | - | 0.13 | 0.11 | 0.09 | 0.08 | 0.07 | 0.07 |
| Net block | - | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Capital work in progress | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | - | 27.43 | 37.38 | 18.94 | 6.30 | 7.20 | 5.55 |
| Sundry debtors | - | 46.28 | 30.94 | 28.53 | 26.97 | 14.95 | 11.20 |
| Cash & bank balances | - | 0.43 | 13.88 | 5.69 | 0.21 | 0.25 | 0.18 |
| Loans & advances | - | 58.20 | 50.67 | 24.35 | 2.70 | 2.36 | 1.47 |
| Total current assets | - | 132 | 133 | 77.51 | 36.18 | 24.76 | 18.40 |
| Total current liabilities | - | 76.66 | 75.94 | 37.29 | 24.30 | 11.79 | 8.32 |
| Net working capital | - | 55.68 | 56.93 | 40.22 | 11.88 | 12.97 | 10.08 |
| Total assets | - | 55.72 | 56.96 | 40.27 | 11.93 | 13.00 | 10.12 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | - | 13.88 | 5.69 | 0.21 | 0.25 | 0.18 | 0.12 |
| Net cash from operating activities | - | (9.19) | (5.42) | (20.98) | 2.81 | (2.43) | (3.12) |
| Net cash from investing activities | - | (0.02) | (0.01) | (0.01) | (0.01) | 0.00 | 0.01 |
| Net cash from financing activities | - | (4.24) | 13.62 | 26.47 | (2.84) | 2.50 | 3.17 |
| Net change in cash | - | (13.45) | 8.19 | 5.48 | (0.04) | 0.08 | 0.06 |
| Closing cash | - | 0.43 | 13.88 | 5.69 | 0.21 | 0.25 | 0.18 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +3.4% | -24.0% | +64.5% | +37.3% | +134.7% | +1.5% | - |
| EBITDA growth | +34.2% | +8.7% | +45.8% | +8.3% | +445.0% | -14.9% | - |
| PBT growth | +150.0% | +0.7% | +1.4% | -11.5% | +2516.7% | -25.0% | +33.3% |
| Net income growth | +171.1% | -9.4% | +16.3% | -20.7% | +3766.7% | -62.5% | - |
| Revenue CAGR (3Y) | +8.9% | +19.7% | +74.4% | +48.5% | +53.3% | +23.2% | - |
| EBITDA CAGR (3Y) | +28.6% | +19.7% | +104.9% | +71.2% | +64.5% | +0.9% | - |
| Profitability & leverage | |||||||
| Net income margin | +2.0% | +0.8% | +0.7% | +0.9% | +1.6% | +0.1% | +0.3% |
| Return on capital employed | - | +6.6% | +7.1% | +9.0% | +17.6% | +3.5% | +5.4% |
| Return on net worth | - | +2.6% | +3.5% | +7.0% | +100.9% | +3.5% | +11.5% |
| Debt / equity | - | 0.48 | 0.57 | 1.00 | 9.75 | 19.47 | 14.98 |
| Long-term debt / equity | - | 0.28 | 0.38 | 0.64 | 4.09 | 6.24 | 3.23 |
| Interest cover | 29.14 | 62.20 | 58.77 | 41.28 | 28.11 | 89.74 | 84.78 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 1,041.00 | 1,643.40 | 1,175.65 | 970.13 | 442.86 | 436.29 |
| Inventory turnover | - | 3.85 | 5.84 | 7.92 | 10.78 | 4.86 | 6.87 |
| Debtors turnover | - | 3.24 | 5.53 | 3.60 | 3.47 | 2.37 | 3.05 |
| EPS (₹) | 1.00 | 0.41 | 0.45 | 0.76 | 333.39 | 6.91 | 16.86 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 16.01 | 15.60 | 20.35 | 496.73 | 163.34 | 156.43 |
To see the full year-wise statements and ratios of Dipna Pharmachem Limited, buy the company report.
Board of directors of Dipna Pharmachem Limited
Dipna Pharmachem has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dipna Keyur Shah Also directs: Dipan Pharmachem Private Limited, Dhara Pharmachem Private Limited | Director | 19 Jul 2011 | 15 Years 3 Months | Current |
| Keyur Dipakkumar Shah Also directs: Dipan Pharmachem Private Limited, Dhara Pharmachem Private Limited, Rise Pharma Chem LLP and 1 more | Managing Director | 01 May 2022 | 4 Years 5 Months | Current |
| Jitendra Pradipbhai Parmar Also directs: Sharanam Infraproject and Trading Limited | Additional Director | 11 May 2026 | 0 Years 5 Months | Current |
| Manish Shrichand Bachani Also directs: Scarnose International Limited, Bridge Securities Limited, Add-Shop E-Retail Limited and 2 more | Additional Director | 11 May 2026 | 0 Years 5 Months | Current |
Auditor
Dipna Pharmachem Limited is audited by Devadiya & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Devadiya & Associates | FY 2024 | 123045W |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 9.10%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 90.90%.
Sep 2026
QUARTER
9.10% Promoters
90.90% Retail & Others
Promoter holding - history
Now 9.10% · Sep 2026High 10.00% · Dec 2025Low 9.10% · Jun 2026
Shareholding trend - last 6 quarters
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 9.10% | 9.10% | 10.00% | 10.00% |
| Public | 90.90% | 90.90% | 90.00% | 90.00% |
Charges & borrowings
Open charges
₹11.38 Cr
Satisfied charges
₹4.2 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Oct 2022 | 100628660 | Others | ₹9 Cr | Open | |
| 29 Oct 2022 | 100628676 | Others | ₹23 Lakh | Open | |
| 09 Jun 2021 | 100455641 | Others | ₹2.15 Cr | Open | |
| 07 Aug 2020 | 100365022 | Others | ₹35.49 Lakh | Satisfied | |
| 18 Sep 2015 | 10611821 | Others | ₹2.85 Cr | Satisfied |
To see the full charge records of Dipna Pharmachem Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Dipna Pharmachem Limited has 82 deals on record (79 market trades, 2 rights issues, 1 ipo); the latest was in August 2026.
Total deals
82
Market trades
79
Rights issues
2
IPO
1
Deals on record (5 of 82)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2025 | Market trade | ₹40.5 Lakh | Buyer: an individual Seller: Kalpalabdhi Securities Private Limited |
| Nov 2025 | Market trade | ₹50.3 Lakh | Seller: Kalpalabdhi Securities Private Limited |
| Nov 2025 | Market trade | ₹47.9 Lakh | Seller: Kalpalabdhi Securities Private Limited |
| Nov 2025 | Market trade | ₹46.4 Lakh | Seller: Kalpalabdhi Securities Private Limited |
| Feb 2025 | Market trade | ₹81.6 Lakh | Buyer: an individual Seller: Kalpalabdhi Securities Private Limited , an individual |
To see the full deal history of Dipna Pharmachem Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Dipna Pharmachem Limited has 54 court cases on record: 1 filed by Dipna Pharmachem, 53 filed against it. 31 cases are pending and 23 are disposed.
Total cases
54
Filed by the company
1
Filed against the company
53
Pending
31
Disposed
23
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 54 | 53 | 31 |
Cases on record (5 of 54)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Veeraj International Llp-Shah Samir Vrajlal | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary case) | Filed against the company by Rashi Pharma Care Pvt Ltd Through Director Sanjay Indermal Jain | Pending |
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed against the company by M/S. Covalent Laboratories Pvt. Ltd., Rep. by Eswara Rao | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed against the company by Protium Finance Limited | Pending |
| District court, East, Delhi | Cheque dishonour complaint | Filed against the company by Ster Chem | Pending |
To see the full case history of Dipna Pharmachem Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dipna Pharmachem Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dipna Pharmachem has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AADCD9404F1ZY | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dipna Pharmachem Limited, buy the company report.
Recent activity
Dipna Pharmachem Limited has 10 board changes on record since 2011: 7 appointments and 3 cessations. The latest: Jitendra Pradipbhai Parmar was appointed as Additional Director on 11 May 2026.
Appointed
Jitendra Pradipbhai Parmar was appointed as Additional Director.
Appointed
Manish Shrichand Bachani was appointed as Additional Director.
Filing
Dipna Pharmachem Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Ahmedabad.
Ceased
Nirav M Soni ceased to be Director.
AGM
Dipna Pharmachem Limited last Annual general meeting of members was held on 30 Aug 2025 as per latest MCA records.
Ceased
Jitendra Pradipbhai Parmar ceased to be Director.
Appointed
Nirav M Soni was appointed as Director.
Charges
A charge with Others of Rs. 9.00 Cr registered on 29 Oct 2022 with Charge ID 100628660 was modified on 16 Sep 2023.
Charges
A charge with Others of Rs. 0.23 Cr registered on 29 Oct 2022 with Charge ID 100628676 was modified on 16 Sep 2023.
Charges
A charge registered on 07 Aug 2020 via Charge ID 100365022 with Others was fully satisfied on 31 Jul 2023.
Charges
A charge registered on 18 Sep 2015 via Charge ID 10611821 with Others was fully satisfied on 31 Jul 2023.
Appointed
Jitendra Pradipbhai Parmar was appointed as Director.
14 earlier events are in the company report.
News
Frequently asked questions
Dipna Pharmachem is an active public limited company based in Ahmedabad, Gujarat, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 19 July 2011 (15+ years old) and is registered under CIN L24100GJ2011PLC066400. Listed on BSE: 543594.
Dipna Pharmachem reported revenue of ₹129.11 Cr for FY 2025-26 (up 3.4% YoY) based on standalone financials.
Dipna Pharmachem has 4 current directors:
- Keyur Dipakkumar Shah - Managing Director
- Dipna Keyur Shah - Director
- Jitendra Pradipbhai Parmar - Additional Director
- Manish Shrichand Bachani - Additional Director
The latest financial statements of Dipna Pharmachem on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dipna Pharmachem is 24AADCD9404F1ZY, registered in Gujarat.
The CIN (Corporate Identification Number) of Dipna Pharmachem is L24100GJ2011PLC066400. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Dipna Pharmachem is a listed company as per MCA records. Its shares are listed on BSE (code: 543594).
Dipna Pharmachem has 54 court cases on record: 1 filed by the company and 53 filed against it. 31 are pending.
Dipna Pharmachem was incorporated on 19 July 2011, making it 15+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Dipna Pharmachem has 82 deals on record (79 market trades, 2 rights issues, 1 ipo); the latest was in August 2026.